What Is Neuroinflammation and How Does It Affect Mental Health?

Your Brain Has an Immune System. And It Might Be Attacking You.

You probably learned in school that the brain is "immune-privileged." Protected behind the blood-brain barrier, sealed off from the messy biological warfare that the rest of your body wages against infections and injuries. A pristine command center, untouched by the inflammation raging in your joints, your gut, or your bloodstream.

That story is wrong. Not a little wrong. Fundamentally, profoundly wrong.

Your brain has its own immune system. It has its own immune cells, called microglia, that patrol the neural landscape like a standing army. And when that army gets the wrong signal, or gets stuck in combat mode, it doesn't just defend the brain. It damages it. It chews up synapses. It floods neural circuits with toxic molecules. It rewires the neurochemical systems that regulate your mood, your memory, and your ability to think clearly.

This process, neuroinflammation, is now recognized as a central driver of depression, anxiety, cognitive decline, and a growing list of psychiatric conditions. And the story of how scientists figured this out is one of the most important paradigm shifts in modern medicine.

The Cells That Guard Your Brain (And Sometimes Betray It)

To understand neuroinflammation, you need to meet the microglia. They're the most underappreciated cells in neuroscience.

Microglia make up roughly 10-15% of all cells in the brain. They're not neurons. They're immune cells that took up permanent residence in your central nervous system during embryonic development. Think of them as the brain's combination of security guards, janitors, and construction crews. In their resting state (scientists call it "ramified"), they extend long, delicate branches that constantly survey their local environment, checking for damage, infection, or debris.

When microglia detect a problem, they activate. They retract their branches, swell into an amoeba-like shape, and start doing immune system things: engulfing cellular debris, releasing inflammatory signaling molecules called cytokines, and recruiting more immune activity to the area. This is the brain's inflammatory response, and in short bursts, it's entirely healthy. You bang your head, microglia clean up the damage. A virus sneaks past the blood-brain barrier, microglia mount a defense.

The problem begins when microglia get stuck in their activated state. When the "off switch" breaks.

Chronic microglial activation is like a fire alarm that won't stop ringing. The alarm itself starts causing damage. Activated microglia release pro-inflammatory cytokines (IL-1beta, IL-6, TNF-alpha) continuously. They produce reactive oxygen species that cause oxidative stress. And most disturbingly for mental health, they start pruning synapses that don't need pruning, literally dissolving the connections between neurons that underlie healthy brain function.

A landmark 2015 study published in Nature Medicine used PET imaging to show that people with major depression had significantly higher microglial activation in the prefrontal cortex, anterior cingulate cortex, and insula compared to healthy controls. The more activated the microglia, the more severe the depression. The brain's own immune system was actively undermining the circuits responsible for mood regulation.

The Tryptophan Trap: How Inflammation Steals Your Serotonin

Here's where the connection between inflammation and mental health gets biochemically precise, and genuinely surprising.

You've heard of serotonin. The "happiness neurotransmitter" (a simplification, but not entirely wrong). Serotonin is synthesized from an amino acid called tryptophan. Under normal conditions, tryptophan enters the brain and gets converted into serotonin by an enzyme called tryptophan hydroxylase. Simple supply chain.

Neuroinflammation hijacks this supply chain.

When pro-inflammatory cytokines flood the brain, they activate a competing enzyme called indoleamine 2,3-dioxygenase (IDO). IDO diverts tryptophan away from serotonin production and shunts it down an alternative metabolic pathway called the kynurenine pathway. Instead of becoming serotonin, your tryptophan gets converted into kynurenine and then into a series of downstream metabolites, some of which are genuinely neurotoxic.

One of these metabolites, quinolinic acid, is an agonist of NMDA receptors. At elevated concentrations, it produces excitotoxicity, essentially overstimulating neurons until they're damaged or die. Another metabolite, 3-hydroxykynurenine, generates free radicals that cause oxidative damage.

So inflammation doesn't just reduce serotonin. It actively converts serotonin's raw material into brain-damaging compounds. Your immune system is simultaneously depleting the neurotransmitter you need for emotional stability and producing molecules that directly injure the neurons that use it.

This discovery, published across dozens of studies throughout the 2010s, solved a long-standing puzzle in psychiatry: why do roughly one-third of depressed patients not respond to SSRIs (selective serotonin reuptake inhibitors)? If their depression is driven by inflammation rather than a primary serotonin deficit, then keeping existing serotonin in the synapse longer (what SSRIs do) won't help much. There isn't enough serotonin to keep around in the first place. The factory has been sabotaged.

Beyond Serotonin: The Full Cascade

The tryptophan trap is dramatic, but it's only one pathway through which neuroinflammation disrupts mental health. The full picture involves at least four major mechanisms working simultaneously.

BDNF Suppression: Cutting Off the Growth Signal

Brain-derived neurotrophic factor (BDNF) is essentially fertilizer for neurons. It supports the survival of existing neurons, encourages the growth of new synaptic connections, and is critical for the neuroplasticity that allows your brain to adapt, learn, and recover from stress.

Pro-inflammatory cytokines suppress BDNF production. This has been demonstrated in cell cultures, animal models, and human studies. People with elevated inflammatory markers consistently show reduced circulating BDNF levels. And BDNF reduction is one of the most consistently replicated findings in depression research.

Without adequate BDNF, the brain loses its ability to remodel itself. Stressed circuits can't repair. New learning is impaired. The hippocampus, a structure critical for memory and mood regulation, actually shrinks. Brain imaging studies show measurable hippocampal volume reduction in chronically depressed patients, and this reduction correlates with both inflammation levels and illness duration.

Glutamate Excitotoxicity: Too Much of a Good Thing

Glutamate is the brain's primary excitatory neurotransmitter. Under normal conditions, it's essential for everything from learning to sensory processing. But glutamate signaling is a tightrope walk. Too little and neural communication breaks down. Too much and neurons literally excite themselves to death.

Neuroinflammation pushes the system toward excess. Activated microglia release glutamate directly. The quinolinic acid produced through the kynurenine pathway stimulates NMDA receptors, amplifying glutamate signaling further. And inflammation impairs the astrocytes (support cells) that normally clear excess glutamate from synapses.

The result is a brain swimming in excitatory signaling. This contributes to the anxiety, insomnia, and cognitive "wiring" feeling that many people with inflammatory conditions describe. It also causes direct neuronal damage over time, particularly in the hippocampus and prefrontal cortex.

HPA Axis Dysregulation: The Stress System Goes Haywire

The hypothalamic-pituitary-adrenal (HPA) axis is your body's central stress response system. When you face a threat, the hypothalamus signals the pituitary, which signals the adrenal glands, which release cortisol. Cortisol mobilizes energy, suppresses non-essential functions, and prepares you to fight or flee. Once the threat passes, cortisol itself acts as a feedback signal to shut the system down.

Pro-inflammatory cytokines can activate the HPA axis directly. They can also impair the negative feedback loop that's supposed to shut it down, leading to chronically elevated cortisol. And chronic cortisol elevation is neurotoxic. It damages hippocampal neurons, impairs prefrontal cortex function, and promotes further inflammation, creating a vicious cycle.

This is one of the key ways that psychological stress and biological inflammation feed each other. Stress causes inflammation. Inflammation dysregulates the stress response. The dysregulated stress response causes more inflammation. Breaking this cycle is one of the central challenges of treating inflammation-driven mental illness.

Brainwave data, captured at 256Hz across 8 channels, processed on-device. The Crown's open SDKs let developers build brain-responsive applications.

Explore the Crown

What Neuroinflammation Looks Like on EEG

You can't put inflammatory cytokines on an EEG screen. But you can see what they do to neural signaling. And the EEG signature of neuroinflammation is increasingly well-characterized.

The Alpha Slowdown

One of the most consistent EEG findings in neuroinflammatory states is a reduction in alpha peak frequency. In a healthy brain, alpha oscillations peak somewhere between 9.5 and 11.5 Hz. In people with active neuroinflammation, whether from infection, autoimmune disease, or chronic stress, this peak shifts lower, sometimes dropping below 9 Hz.

A remarkable 2019 study in Brain, Behavior, and Immunity gave healthy volunteers an injection of lipopolysaccharide (LPS), a bacterial molecule that triggers a controlled inflammatory response. Within hours, as inflammatory markers spiked in their blood, their alpha peak frequency dropped by nearly 1 Hz. Their brains literally slowed down as inflammation rose. When the inflammation resolved, alpha frequency returned to baseline.

This finding connects to the subjective experience of "brain fog" that accompanies inflammatory conditions. The alpha rhythm acts as a kind of timing signal for cortical processing. When it slows, everything downstream slows with it: processing speed, working memory, attention.

Theta Power Increases

Elevated frontal theta (4-8 Hz) is another hallmark of neuroinflammatory states. Theta elevations have been documented in chronic fatigue syndrome, long COVID, post-treatment Lyme disease, and autoimmune encephalitis. In each case, higher theta correlates with worse cognitive performance and more severe subjective fatigue.

The likely mechanism involves inflammation-driven changes in thalamocortical signaling. The thalamus, which normally regulates cortical arousal states, becomes dysregulated by inflammatory cytokines. The result is a brain that drifts toward drowsy, under-aroused states even during tasks that should command full alertness.

Connectivity Disruption

Perhaps the most sophisticated EEG finding involves changes in functional connectivity, how well different brain regions communicate with each other. Neuroinflammation appears to disrupt long-range connectivity while increasing local, short-range connectivity. In practical terms, the brain's ability to coordinate large-scale networks (like the default mode network or the executive control network) deteriorates, while isolated patches of neural tissue become hyperactive.

This pattern shows up in coherence analyses, where researchers measure how synchronized EEG signals are between distant electrode pairs. Studies of people with active inflammation consistently show reduced frontal-parietal coherence and increased local frontal coherence, a signature that looks remarkably like the EEG pattern seen in depression.

The Body-Brain Pipeline: How Inflammation Gets In

For years, the blood-brain barrier was treated as an impenetrable wall. Inflammation in the body stayed in the body. The brain was protected.

We now know that the blood-brain barrier is more like a selective checkpoint. And inflammation has multiple ways to get through it.

First, pro-inflammatory cytokines don't need to cross the barrier at all. They can signal through it. The blood-brain barrier is lined with receptors that detect circulating cytokines and relay inflammatory signals to microglia on the other side. Your gut inflammation can activate your brain's immune system without a single inflammatory molecule physically entering the brain.

Second, chronic inflammation can compromise the blood-brain barrier itself, making it leaky. Once the barrier is compromised, immune cells and inflammatory molecules that normally stay in the bloodstream can infiltrate brain tissue directly.

Third, the vagus nerve, the longest cranial nerve, runs from the brainstem to the gut and provides a direct neural highway for inflammatory signals. Activation of immune cells in the gut triggers vagal afferents that signal the brain within minutes.

This is why conditions you'd never think of as "brain diseases" can produce psychiatric symptoms. Rheumatoid arthritis, inflammatory bowel disease, psoriasis, chronic infections, even obesity (which produces chronic low-grade inflammation through visceral fat). All of them are associated with elevated rates of depression and anxiety. Not because being sick is depressing (though it is), but because the inflammation driving these conditions is simultaneously inflaming the brain.

What This Means for Treatment (And Why It Matters So Much)

The neuroinflammation framework doesn't replace existing models of mental illness. It deepens them. Serotonin still matters. Psychological trauma still matters. Genetics still matter. But inflammation provides a biological mechanism that connects all of these factors in ways that were previously invisible.

A person inherits genes that make their microglia more reactive. They experience childhood adversity that primes their stress response. They develop a gut microbiome that promotes inflammation. They eat a pro-inflammatory diet. They don't sleep enough. Each of these factors independently contributes to neuroinflammation, and the cumulative effect is a brain whose immune system has turned against its own function.

This understanding opens treatment avenues that didn't exist when psychiatry thought in purely neurochemical terms. Anti-inflammatory interventions, from omega-3 fatty acids to targeted cytokine inhibitors, are showing genuine antidepressant effects in clinical trials, particularly for patients who don't respond to traditional antidepressants. Exercise, which is a potent anti-inflammatory, produces effects comparable to SSRIs in some depression trials. Even dietary interventions that reduce systemic inflammation (Mediterranean diet, reduced refined sugar) show measurable improvements in mood.

And then there's the monitoring piece. If neuroinflammation produces characteristic changes in brainwave patterns, then EEG becomes a potential tracking tool. Not for measuring inflammation directly, but for measuring its neural consequences in real-time.

Tracking the Neural Consequences With EEG

The EEG changes associated with neuroinflammation, reduced alpha, elevated theta, altered connectivity, are exactly the kinds of signals that modern consumer EEG can capture. And tracking these patterns over time may be one of the most practical things a person concerned about brain inflammation can do.

The Neurosity Crown's 8 channels cover positions across frontal (F5, F6), central (C3, C4), centro-parietal (CP3, CP4), and parietal-occipital (PO3, PO4) regions. This distribution lets you track alpha power and peak frequency across posterior regions, monitor frontal theta, and compute coherence between distant electrode pairs. At 256Hz sampling, the signal captures everything from delta through gamma with room to spare.

What makes this practically useful isn't a single recording. It's the trend over time. If you're implementing anti-inflammatory interventions (better sleep, exercise, dietary changes, stress reduction), tracking your brainwave patterns week over week gives you objective feedback on whether those interventions are producing measurable neural changes. Is your alpha peak frequency trending upward? Is frontal theta decreasing? These are the kinds of questions that EEG can answer.

For developers and researchers, the Crown's SDK and MCP integration make it possible to build applications that correlate EEG biomarkers with self-reported symptoms, lifestyle data, and even inflammatory blood markers. The research connecting EEG patterns to neuroinflammation is still young, and the tools to push it forward are now accessible outside of institutional labs.

The Frontier: Inflammation, EEG, and the Future of Psychiatric Diagnosis

The biggest promise of the neuroinflammation framework isn't any single treatment. It's the possibility of precision psychiatry, matching patients to treatments based on their specific biological profile rather than trial-and-error prescribing.

Right now, if you walk into a psychiatrist's office with depression, you'll likely be prescribed an SSRI. If that doesn't work after six weeks, you'll try another one. Then maybe a different class of medication. The average time to find an effective treatment for depression is 6-14 months. That's months of suffering while playing pharmaceutical roulette.

But if we could identify, at the point of diagnosis, whether a patient's depression is inflammation-driven (elevated CRP, reduced alpha peak frequency, disrupted frontal-parietal coherence) versus a primary neurotransmitter imbalance (normal inflammatory markers, different EEG profile), we could route them to the right treatment from day one.

This isn't science fiction. The biomarkers exist. The measurement tools exist. What's missing is the large-scale research connecting specific EEG profiles to specific treatment responses. And that research is accelerating, in part because consumer EEG devices have made it possible to collect neural data at scales that were previously impossible.

Your Brain Is Not a Sealed Vault

The old model of the brain as an immunologically isolated organ, untouched by the body's inflammatory processes, was comforting. It implied that your brain was safe. Protected. Separate from the messy biology of disease and immunity.

The new model is less comforting but far more useful. Your brain is in constant dialogue with your immune system. The state of your gut, your sleep, your stress levels, your diet, and your physical health all speak to your microglia. And your microglia speak back, in the language of synaptic pruning, neurotransmitter disruption, and altered electrical signaling.

This means that mental health is, in a very real sense, whole-body health. It means that the inflammation from a chronic infection, a food intolerance, or a sedentary lifestyle isn't just affecting your joints or your waistline. It's affecting the organ that generates your thoughts, your emotions, and your sense of self.

It also means that you have more levers for protecting your mental health than psychiatry traditionally acknowledged. Every anti-inflammatory choice you make, every night of adequate sleep, every hour of exercise, every meditation session that calms your stress response, is a choice that reduces the immune assault on your brain.

The signals are there. The brainwave patterns that neuroinflammation disrupts are measurable, trackable, and increasingly interpretable. We're still in the early chapters of understanding this connection, but the trajectory is clear: the era of treating the brain as separate from the body is over. And what comes next, the integration of immune monitoring, neural tracking, and personalized intervention, might be the most important advance in mental health care in a generation.